CD44 and neoplasm: Recently, one study has shown that MMP9 forms a complex with the hyaluronan receptor CD44 on the surface of breast cancer cells and activates downstream TGF-β, facilitating tumour cell survival, invasion and metastasis (Yu and Stamenkovic, 2004).